© 2019 IPHARMA

  • Facebook Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

Cases and

webinars

Webinar “Highlights of the next-in-class drugs development”

The development of pharmacologically similar agents and improved analogues of innovative drugs (next-in-class) is one of the target directions in evolution of Russian pharmaceutical industry under the “Pharma 2020” program.

What will we discuss in Webinar?

  • the advantages and risks of next-in-class drug development

  • specifics of these drugs clinical trials program planning

  • the applicability of adaptive designs using  in clinical trials of the next-in-class drug on the example of different pharmacological classes

For whom?

For drug developers, pharmaceutical and biotech companies, participants in the clinical trial market, doctors. 

Hosts:

Natalia Vostokova, IPHARMA Chief Operating Officer

Julia Tahtenberg, IPHARMA Medical Director